Post-discharge Malaria Chemoprevention Implementation Trial in Benin

Recruiting now · Phase 4

Conditions studied: Severe Malaria, Severe Anaemia

In brief

The proposed research aims to conduct implementation trials in Benin, co-designed with national stakeholders, to evaluate different delivery strategies for optimizing health system delivery of post-discharge malaria chemoprevention (PDMC) drugs and adherence to PDMC. This chemoprevention strategy is effective in reducing hospital readmissions and deaths after discharge. However, there is no clear delivery platform for PDMC, and adherence to the 3-day dosing regimen, provided monthly three times after discharge, is a potential limitation. The current trial will provide evidence-based data on acceptability, feasibility, and cost-effectiveness to aid decision-makers. The evidence generated will be used to support the effective implementation and scale-up of PDMC in high malaria-endemic areas such as Benin.

Key facts

Study ID
NCT06601712
Run by
Institut de Recherche Clinique du Benin
People needed
648
Starts
2025-07-02
Expected to finish
2026-12-31
Last updated by the study team
2025-07-24

Who can join

Age: any, up to 9. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.